Anneli Uusküla, MD, PhD
University of Tartu - Professor, Department of Family Medicine and Public Health
University of Tartu - Attending Physician, Clinic of Dermatology
MD, University of Tartu
PhD, University of Tartu
MSc, Epidemiology, University at Albany, State University of New York
Research Interests
HIV, STI, Drug Use, Epidemiology
Anneli Uusküla is a professor at the Department of Public Health, and physician practicing Dermatovenerology at the University of Tartu, Estonia. She has been in medicine and public health for over 20 years. Dr. Uusküla has received a number of research grants and continues to have ongoing financial support for the research in the fields of HIV, sexually transmitted infections and injection drug use from the United States National Institutes of Health, European Center for Disease Control and Prevention, and UNAIDS/National Centre in HIV Epidemiology and Clinical Research. She also serves as a member and a technical expert for several highly reputable professional organizations such as the European Medicines Agency (EMEA), European Center for Disease Control and Prevention (ECDC), and Estonian Research Council.


Uuskula A, Feelemyer J, Des Jarlais DC (2023).
HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: A scoping review
European Journal of Public Health [Epub 2023 Feb 1]. doi: 10.1093/eurpub/ckad008.

Uuskula A, Keis A, Toompere K, Planken A, Rebrov K (2022).
Cluster randomised, controlled, triple-blind trial assessing the efficacy of intranasally administered virus-neutralising bovine colostrum supplement in preventing SARS-CoV-2 infection in household contacts of SARS-CoV-2-positive individuals: A study protocol
Trials, 23 (1), 92. doi: 10.1186/s13063-022-06039-9. PMCID: PMC8801927.

Wiessing L, Kalamara E, Stone J, ..., Uuskula A, ..., Vickerman P (2021).
Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 – is the precautionary principle applicable?
Eurosurveillance, 26 (49), 2002093. doi: 10.2807/1560-7917.ES.2021.26.49.2002093. PMCID: PMC8662800.

Uuskula A, Talu A, Rannap J, Barnes DM, Des Jarlais D (2021).
Rapid point-of-care (POC) testing for hepatitis C antibodies in a very high prevalence setting: Persons injecting drugs in Tallinn, Estonia
Harm Reduction Journal, 18 (1), 39. doi: 10.1186/s12954-021-00485-5. PMCID: PMC8015736.

Tisler A, Ojavee SE, Veerus P, Soodla P, Uuskula A (2023).
Cervical cancer screening patterns among HIV-positive women in Estonia: A population-based retrospective cohort study
BMC Cancer, 21 (1), 350. doi: 10.1186/s12885-021-08076-0. PMCID: PMC8017631.


Low N, Redmond S, Uuskula A, van Bergen J, Ward H, Andersen B, Gotz H (2016).
Screening for genital chlamydia infection
Cochrane Database of Systematic Reviews, 9, CD010866. doi: 10.1002/14651858.CD010866.pub2.

Dr. Uusküla's MyBibliography Profile